Challenges in breast cancer management and prevention

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61: 69-90. 10.3322/caac.20107. Brewster AM, Bedrosian I, Parker PA, Dong W, Peterson SK, Cantor SB, Crosby M, Shen Y: Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status. Cancer. 2012, 118: 5637-5643. 10.1002/cncr.27574. Jorgensen KJ, Gotzsche PC: Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ. 2009, 339: b2587-10.1136/bmj.b2587. Golubnitschaja O, Yeghiazaryan K, Costigliola V, Trog D, Braun M, Debald M, Kuhn W, Schild HH: Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?. EPMA J. 2013, 4: 6-10.1186/1878-5085-4-6. Debald M, Yeghiazaryan K, Cebioglu M, Kuhn W, Schild HH, Golubnitschaja O: “Suspect molecular signature” in blood as the indicator for undiagnosed breast cancer, cancer risk and targeted prevention. EPMA J. 2013, 4 (22):